Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M., A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma., «ANNALS OF ONCOLOGY», 2012, 23, pp. 415 - 420 [articolo]
R. Tonelli; A. McIntyre; C. Camerin; Z.S. Walters; K. Di Leo; J. Selfe; S. Purgato; E. Missiaglia; A. Tortori; J. Renshaw; A. Astolfi; K.R. Taylor; S. Serravalle; R. Bishop; C. Nanni; L.J. Valentijn; A. Faccini; I. Leuschner; S. Formica; Jorge S Reis-Filho9; V. Ambrosini; K. Thway; M. Franzoni; B. Summersgill; R. Marchelli; P. Hrelia; G. Cantelli-Forti; S. Fanti; R. Corradini; A. Pession; J. Shipley, Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy, «CLINICAL CANCER RESEARCH», 2012, 18, pp. 796 - 807 [articolo]
Treglia G; Castaldi P; Villani MF; Perotti G; de Waure C; Filice A; Ambrosini V; Cremonini N; Santimaria M; Versari A; Fanti S; Giordano A; Rufini V., Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 569 - 580 [articolo]
Piccardo A.; Lopci E.; Conte M.; Garaventa A.; Foppiani L.; Altrinetti V.; Nanni C.; Bianchi P.; Cistaro A.; Sorrentino S.; Cabria M.; Pession A.; Puntoni M.; Villavecchia G.; Fanti S., Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 57 - 71 [articolo]
P. Spinnato; A. Bazzocchi; A. Brioli; C. Nanni; E. Zamagni; U. Albisinni; M. Cavo; S. Fanti; G. Battista; E. Salizzoni, Contrast enhanced MRI and (18)F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease, «EUROPEAN JOURNAL OF RADIOLOGY», 2012, 81, pp. 4013 - 4018 [articolo]
Zinzani P.L.; Rigacci L.; Stefoni V.; Broccoli A.; Puccini B.; Castagnoli A.; Vaggelli L.; Zanoni L.; Argnani L.; Baccarani M.; Fanti S., Early interim 18F-FDG PET in Hodgkin's lymphoma: evaluation on 304 patients., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 4 - 12 [articolo]
Ambrosini V.; Savelli F.; Merli E.; Zompatori M.; Nanni C.; Allegri V.; Fanti S., F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease, «CLINICAL NUCLEAR MEDICINE», 2012, 37, pp. 196 - 197 [articolo]
C. Nanni;L. Boriani;C. Salvadori;E. Zamparini;G. Rorato;V. Ambrosini;A. Gasbarrini;F. Tumietto;F. Cristini;L. Scudeller;S. Boriani;P. Viale;S. Fanti, FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 1538 - 1544 [articolo]
Lopci E; Zanoni L; Chiti A; Fonti C; Santi I; Zinzani P.L.; Fanti S., FDG PET/CT predictive role in follicular lymphoma., «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 864 - 871 [articolo]
Cerci J.J.; Zanoni L.; Meneghetti J.C.; Fanti S., FDG- PET in Lymphoma: Nuclear Medicine Perspective., in: ELSTROM R.L. SCHUSTER S.J., PET imaging of Lymphoma, PHILADELPHIA, W.B. Saunders Company-Elsevier, 2012, pp. 21 - 33 [capitolo di libro]
Lopci E.; D'Ambrosio D.; Nanni C.; Chiti A.; Pession A.; Marengo M.; Fanti S., Feasibility of carbidopa premedication in pediatric patients: a pilot study., «CANCER BIOTHERAPY & RADIOPHARMACEUTICALS», 2012, 27, pp. 729 - 733 [articolo]
Hartmann S; Agostinelli C; Diener J; Döring C; Fanti S; Zinzani PL; Gallamini A; Bergmann L; Pileri S; Hansmann ML., GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers., «BMC CANCER», 2012, 12, Article number: 586, pp. 1 - 7 [articolo]Open Access
Ambrosini V.; Campana D.; Nanni C.; Cambioli S.; Tomassetti P.; Rubello D.; Fanti S., Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2012, 39, pp. 1278 - 1283 [articolo]
Celli M.; Fanti S., Na 18F PET in Oncology., «IMAGING IN MEDICINE», 2012, 4, pp. 89 - 106 [articolo]
V. Ambrosini; D. Campana; P. Tommassetti; S. Fanti, Neuroendocrine Tumours with Secondary Liver Lesions, in: Valentina Ambrosini Piero Amodio Lasse K. Bak Ignasi Barba Ludvik Bass Davide Campana Laia Chavarria Juan Córdoba Dominique Delbeke Stefano Fanti Kim Frisch Alan F. Hofmann Laurie B. Jones-Jackson Susanne Keiding Alan H. Lockwood Patricia Iozzo Mark J.W. McPhail Carlo Merkel Sara Montagnese Ole Lajord Munk Pirjo Nuutila Peter Ott Hanne Prytz Arne Schousboe Michael Sørensen Simon D. Taylor-Robinson Howard C. Thomas Paola Tomassetti Hendrik Vilstrup Helle S. Waagepetersen Ronald C. Walker, Functional Molecular Imaging In Hepatology, OAK PARK, bentham science pubblisher, 2012, pp. 120 - 128 [capitolo di libro]
